BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15259648)

  • 21. Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study.
    de Figueiredo BH; Antoine M; Trouette R; Lagarde P; Petit A; Lamare F; Hatt M; Fernandez P
    Radiat Oncol; 2014 Dec; 9():300. PubMed ID: 25534014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
    Nkhali L; Thureau S; Edet-Sanson A; Doyeux K; Benyoucef A; Gardin I; Michel P; Vera P; Dubray B
    Acta Oncol; 2015 Jun; 54(6):909-15. PubMed ID: 25417733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of functional imaging in the definition of target volumes for lung cancer radiotherapy].
    Thureau S; Hapdey S; Vera P
    Cancer Radiother; 2016 Oct; 20(6-7):699-704. PubMed ID: 27614514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-fluorodeoxyglucose positron emisson tomography/computed tomography guided conformal brachytherapy for cervical cancer.
    Nam H; Huh SJ; Ju SG; Park W; Lee JE; Choi JY; Kim BT; Kim CK; Park BK
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e29-34. PubMed ID: 22503526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer.
    Choi W; Lee SW; Park SH; Ryu JS; Oh SJ; Im KC; Choi EK; Kim JH; Jung SH; Kim S; Ahn SD
    Radiother Oncol; 2010 Nov; 97(2):176-82. PubMed ID: 20855118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusion.
    Janssen MH; Aerts HJ; Buijsen J; Lambin P; Lammering G; Öllers MC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):849-55. PubMed ID: 21392896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The impact of integrating images of positron emission tomography with computed tomography simulation on radiation therapy planning].
    Touboul E; Deniaud-Alexandre E; Moureau-Zabotto L; Lerouge D
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S29-35. PubMed ID: 15679244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
    Devic S; Tomic N; Faria S; Menard S; Lisbona R; Lehnert S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1555-62. PubMed ID: 20646840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative pulmonary single photon emission computed tomography for radiotherapy applications.
    Scarfone C; Jaszczak RJ; Gilland DR; Greer KL; Munley MT; Marks LB; Coleman RE
    Med Phys; 1999 Aug; 26(8):1579-88. PubMed ID: 10501058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
    Lõcsei Z; Hideghéty K; Farkas R; Bellyei S; Sárosi V; Sebestyén K; Sebestyén Z; Kovács P; Mangel L
    Magy Onkol; 2011 Nov; 55(4):274-80. PubMed ID: 22128310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single photon emission computed tomography (SPECT) or positron emission tomography (PET) imaging for radiotherapy planning in patients with lung cancer: a meta-analysis.
    Lee SJ; Park HJ
    Sci Rep; 2020 Sep; 10(1):14864. PubMed ID: 32913277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing lung function using contrast-enhanced dual-energy computed tomography for potential applications in radiation therapy.
    Lapointe A; Bahig H; Blais D; Bouchard H; Filion É; Carrier JF; Bedwani S
    Med Phys; 2017 Oct; 44(10):5260-5269. PubMed ID: 28718888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of dose painting of lung tumours using alanine/EPR dosimetry.
    Knudtsen IS; Svestad JG; Skaug Sande EP; Rekstad BL; Rødal J; van Elmpt W; Öllers M; Hole EO; Malinen E
    Phys Med Biol; 2016 Mar; 61(6):2243-54. PubMed ID: 26913997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?
    Abramyuk A; Tokalov S; Zöphel K; Koch A; Szluha Lazanyi K; Gillham C; Herrmann T; Abolmaali N
    Radiother Oncol; 2009 Jun; 91(3):399-404. PubMed ID: 19168248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
    van Loon J; Offermann C; Bosmans G; Wanders R; Dekker A; Borger J; Oellers M; Dingemans AM; van Baardwijk A; Teule J; Snoep G; Hochstenbag M; Houben R; Lambin P; De Ruysscher D
    Radiother Oncol; 2008 Apr; 87(1):49-54. PubMed ID: 18342967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.